The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
After finishing at $0.40 in the prior trading day, Windtree Therapeutics Inc (NASDAQ: WINT) closed at $0.34, down -15.32%. In other words, the price has decreased by -$15.32 from its previous closing price. On the day, 1.79 million shares were traded. WINT stock price reached its highest trading level at $0.4 during the session, while it also had its lowest trading level at $0.2654.
Ratios:
Our goal is to gain a better understanding of WINT by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.35 and its Current Ratio is at 1.35. In the meantime, Its Debt-to-Equity ratio is 4.96 whereas as Long-Term Debt/Eq ratio is at 4.77.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Ladenburg Thalmann on June 26, 2020, initiated with a Buy rating and assigned the stock a target price of $12.25.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 27 ’23 when Fraser Craig bought 2,500 shares for $1.02 per share. The transaction valued at 2,550 led to the insider holds 57,877 shares of the business.
Fraser Craig bought 2,500 shares of WINT for $2,250 on Sep 26 ’23. The President and CEO now owns 55,377 shares after completing the transaction at $0.90 per share. On Apr 26 ’23, another insider, Fraser Craig, who serves as the President and CEO of the company, bought 1,497 shares for $1.77 each. As a result, the insider paid 2,650 and bolstered with 7,010 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, WINT now has a Market Capitalization of 3120458 and an Enterprise Value of 11961974.
Stock Price History:
Over the past 52 weeks, WINT has reached a high of $11.98, while it has fallen to a 52-week low of $0.28. The 50-Day Moving Average of the stock is -8.18%, while the 200-Day Moving Average is calculated to be -60.09%.
Shares Statistics:
The stock has traded on average 199.15K shares per day over the past 3-months and 409030 shares per day over the last 10 days, according to various share statistics. A total of 9.18M shares are outstanding, with a floating share count of 7.97M. Insiders hold about 13.24% of the company’s shares, while institutions hold 2.94% stake in the company. Shares short for WINT as of 1711584000 were 39651 with a Short Ratio of 0.20, compared to 1709164800 on 58407. Therefore, it implies a Short% of Shares Outstanding of 39651 and a Short% of Float of 0.43.
Earnings Estimates
A comprehensive evaluation of Windtree Therapeutics Inc (WINT) is underway, with the input of SiNtx Technologies, Inc. analysts contributing to its current rating.The consensus estimate for the next quarter is $18.55, with high estimates of $95.30 and low estimates of $23.86.
